Apoptosis as a therapeutic paradigm in inflammatory bowel diseases

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 4, 2006, Pages 406-412

  Verstege, Marleen I ^a   Te Velde, Anje A ^a   Hommes, Daan W ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; DEATH RECEPTOR; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PROTEIN BCL 2; PROTEIN BCL XL; SALAZOSULFAPYRIDINE; SULFAPYRIDINE; THIOGUANINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

APOPTOSIS; CELL CYCLE; CONFERENCE PAPER; CROHN DISEASE; DNA DAMAGE; DRUG INHIBITION; DRUG MECHANISM; ENTERITIS; EPITHELIUM CELL; HUMAN; HYPOXIA; MITOCHONDRION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; T LYMPHOCYTE; ULCERATIVE COLITIS;

APOPTOSIS; CELL CYCLE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; T-LYMPHOCYTES;

EID: 33846966339     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. ZELINKOVA Z., VAN BEELEN A.J., DE KORT F., VER LOREN VAN THEMAAT E., TE VELDE A.A., DE JONG E.C., VAN DEVENTER S.J., HOMMES D.W. Gene expression profile in Crohn's disease related NOD2 variants. Gastroenterology, 2006, 130 : A-363.
2. ZUZARTE-LUIS V., HURLE J.M. Programmed cell death in the developing limb. Int. J. Dev. Biol., 2002, 46 (7) : 871-6.
3. HUTCHINS J.B., BARGER S.W. Why neurons die : cell death in the nervous system. Anat. Rec., 1998 June, 253 (3) : 79-90.
4. MEIER P., FINCH A., EVAN G. Apoptosis in development. Nature, 2000 October 12, 407 (6805) : 796-801.
5. RATHMELL J.C., THOMPSON C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell, 2002 April, 109 Suppl : S97-107.
6. FADEEL B., ORRENIUS S., ZHIVOTOVSKY B. Apoptosis in human disease : a new skin for the old ceremony ? Biochem. Biophys. Res. Commun., 1999 December 29, 266 (3) : 699-717.
7. BU P., KESHAVARZIAN A., STONE D.D., LIU J., LE P.T., FISHER S., QIAO L. Apoptosis : one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J. Immunol., 2001 May 15, 166 (10) : 6399-403.
8. HALL P.A., COATES P.J., ANSARI B., HOPWOOD D. Regulation of cell number in the mammalian gastrointestinal tract : the importance of apoptosis. J. Cell. Sci., 1994 December, 107 (Pt 12) : 3569-77.
9. SARASTE A., PULKKI K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res., 2000 February, 45 (3) : 528-37.
10. LEIST M., JAATTELA M. Four deaths and a funeral : from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol., 2001 August, 2 (8) : 589-98.
11. HANNON G.J., BEACH D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature, 1994 September 15, 371 (6494) : 257-61.
12. REYNISDOTTIR I., POLYAK K., IAVARONE A., MASSAGUE J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes. Dev., 1995 August 1, 9 (15) : 1831-45.
13. SAKURABA H., ISHIGURO Y., YAMAGATA K., TAGAWA Y., IWAKURA Y, SEKIKAWA K., MUNAKATA A., NAKANE A. Transforming growth factor-{beta} regulates susceptibility of epithelial apoptosis in murine model of colitis. Ann. N Y Acad. Sci., 2004 December, 1029 : 382-4.
14. VETUSCHI A., LATELLA G., SFERRA R., CAPRILLI R., GAUDIO E. Increased proliferation and apoptosis of colonie epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig. Dis. Sci., 2002 July, 47 (7) : 1447-57.
15. SUZUKI A., SUGIMURA K., OHTSUKA K., HASEGAWA K., SUZUKI K., ISHIZUKA K., MOCHIZUKI T., HONMA T., NARISAWA R., ASAKURA H. Fas/Fas ligand expression and characteristics of primed CD45RO+ T cells in the inflamed mucosa of ulcerative colitis. Scand. J. Gastroenterol., 2000 December, 35 (12) : 1278-83.
16. DOERING J., BEGUE B., LENTZE MJ., RIEUX-LAUCAT F., GOULET O., SCHMITZ J., CERF-BENSUSSAN N., RUEMMELE EM. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut, 2004 November, 53 (11) : 1632-8.
17. SOUZA H.S., TORTORI C.J., CASTELO-BRANCO M.T., CARVALHO A.T., MARGALLO V.S., DELGADO C.F., DINES I., ELIA C.C. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease : evidence of altered expression of FasL and perforin cytotoxic pathways. Int. J. Colorectal. Dis., 2005 May, 20 (3) : 277-86.
18. STRATER J., WELLISCH I., RIEDL S., WALCZAK H., KORETZ K., TANDARA A., KRAMMER PH., MOLLER P. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells : a possible role in ulcerative colitis. Gastroenterology, 1997 July, 113 (1) : 160-7.
19. STURM A., LEITE A.Z., DANESE S., KRIVACIC K.A., WEST G.A., MOHR S., JACOBBERGER J.W., FIOCCHI C. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut, 2004 November, 53 (11) : 1624-31.
20. YUKAWA M., IIZUKA M., HORIE Y., YONEYAMA K., SHIRASAKA T., ITOU H., KOMATSU M., FUKUSHIMA T., WATANABE S. Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis. Int. J. Colorectal. Dis., 2002 March, 17 (2) : 70-6.
21. HALE L.P., GOTTFRIED M.R., SWIDSINSKI A. Piroxicam treatment of IL-10-deficient mice enhances colonie epithelial apoptosis and mucosal exposure to intestinal bacteria. Inflamm. Bowel Dis., 2005 December, 11 (12) : 1060-9.
22. VOUSDEN K.H. Activation of the p53 tumor suppressor protein. Biochim. Biophys. Acta, 2002 March 14, 1602 (1) : 47-59.
23. KUBBUTAT M.H., JONES S.N., VOUSDEN K.H. Regulation of p53 stability by Mdm2. Nature, 1997 May 15, 387 (6630) : 299-303.
24. HONDA R., YASUDA H. Association of p19 (ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J., 1999 January 4, 18 (1) : 22-7.
25. HENRIKSSON M., SELIVANOVA G., LINDSTROM M., WIMAN K.G. Inactivation of Myc-induced p53-dependent apoptosis in human tumors. Apoptosis, 2001 February, 6 (1-2) : 133-7.
26. KRISHNA M., WODA B., SAVAS L., BAKER S., BANNER B. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod. Pathol., 1995 August, 8 (6) : 654-7.
27. SCAFFIDI C., FULDA S., SRINIVASAN A., FRIESEN C., LI F., TOMASELLI K.J., DEBATIN K.M., KRAMMER PH., PETER M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J., 1998 March 16, 17 (6) : 1675-87.
28. SARTORIUS U., SCHMITZ I., KRAMMER P.H. Molecular mechanisms of death-receptor-mediated apoptosis. Chembiochem., 2001 January 8, 2 (1) : 20-9.
29. DENAULT J.B., SALVESEN GS. Caspases : keys in the ignition of cell death. Chem. Rev., 2002 December, 102 (12) : 4489-500.
30. BRANNIGAN A.E., O'CONNELL PR., HURLEY H., O'NEILL A., BRADY H.R., FITZPATRICK J.M., WATSON R.W. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock, 2000 May, 13 (5) : 361-6.
31. IRMLER M., THOME M., HAHNE M., SCHNEIDER P., HOFMANN K., STEINER V., BOOMER J.L., SCHROTER M., BURNS K., MATTMANN C., RIMOLDI D., FRENCH L.E., TSCHOPP J. Inhibition of death receptor signals by cellular FLIP. Nature, 1997 July 10, 388 (6638) :, 190-5.
32. THOME M., TSCHOPP J. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol., 2001 October, 1 (1) : 50-8.
33. MONTELEONE I., MONTELEONE G., FINA D., CARUSO R., PETRUZZIELLO C., CALABRESE E., BIANCONE L., PALLONE F. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis. Gastroenterology, 2006 February, 130 (2) : 389-97.
34. BOIRIVANT M., MARINI M., DI FELICE G., PRONIO A.M., MONTESANI C., TERSIGNI R., STROBER W. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology, 1999 March, 116 (3) : 557-65.
35. BREGENHOLT S., PETERSEN T.R., CLAESSON M.H. The majority of lamina propria CD4 (+) T-cells from seid mice with colitis undergo Fas-mediated apoptosis in vivo. Immunol. Lett., 2001 August 1, 78 (1) : 7-12.
36. DECLERCQ W., DENECKER G., FIERS W., VANDENABEELE P. Cooperation of both TNF receptors in inducing apoptosis : involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J. Immunol., 1998 July 1, 161 (1) : 390-9.
37. HARIDAS V., DARNAY B.G., NATARAJAN K., HELLER R., AGGARWAL B.B. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J. Immunol., 1998 April 1, 160 (7) : 3152-62.
38. VANDENABEELE P., DECLERCQ W., VANHAESEBROECK B., GROOTEN J., FIERS W. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol., 1995 March 15, 154 (6): 2904-13.
39. WEISS T., GRELL M., SIEMIENSKI K., MUHLENBECK F., DURKOP H., PFIZENMAIER K., SCHEURICH P., WAJANT H. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol., 1998 September 15, 161 (6): 3136-42.
40. HOLTMANN M.H., DOUNI E., SCHUTZ M., ZELLER G., MUDTER J., LEHR H.A., GERSPACH J., SCHEURICH P., GALLE P.R., KOLLIAS G., NEURATH M.F. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo. Eur. J. Immunol., 2002 November, 32 (11) : 3142-51.
41. ANTONSSON B., MONTESSUIT S., LAUPER S., ESKES R., MARTINOU J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochemical Journal, 2000 January 15, 345 : 271-8.
42. TSUJIMOTO Y., SHIMIZU S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ., 2000 December, 7 (12) : 1174-81.
43. REED J.C., JURGENSMEIER J.M., MATSUYAMA S. Bcl-2 family proteins and mitochondria. Biochimica et Biophysica Acta-Bioenergetics, 1998 August 10, 1366 (1-2) : 127-37.
44. KRAJEWSKI S., KRAJEWSKA M., SHABAIK A., MIYASHITA T., WANG H.G., REED J.C. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol., 1994 December, 145 (6) : 1323-36.
45. OHMAN L., FRANZEN L., RUDOLPH U., BIRNBAUMER L., HORNQUIST E.H. Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis. Gut, 2002 September, 51 (3) : 392-7.
46. ZINGARELLI B., HAKE P.W., BURROUGHS T.J., PIRAINO G., O'CONNOR M., DENENBERG A. Activator protein-1 signalling pathway and apoptosis are modulated by poly (ADP-ribose) polymerase-1 in experimental colitis. Immunology, 2004 December, 113 (4) : 509-17.
47. INA K., ITOH J., FUKUSHIMA K., KUSUGAMI K., YAMAGUCHI T., KYOKANE K., IMADA A., BINION D.G., MUSSO A., WEST G.A., DOBREA G.M., MCCORMICK T.S., LAPETINA E.G., LEVINE A.D., OTTAWAY C.A., FIOCCHI C. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol., 1999 July 15, 163 (2) : 1081-90.
48. ITOH J., DE LA M.C., STRONG S.A., LEVINE A.D., FIOCCHI C. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut, 2001 July, 49 (1) : 35-41.
49. WAHL C., LIPTAY S., ADLER G., SCHMID R.M. Sulfasalazine : a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest., 1998 March 1, 101 (5) : 1163-74.
50. TIEDE I., FRITZ G., STRAND S., POPPE D., DVORSKY R., STRAND D., LEHR H.A., WIRTZ S., BECKER C., ATREYA R., MUDTER J., HILDNER K., BARTSCH B., HOLTMANN M., BLUMBERG R., WALCZAK H., IVEN H., GALLE P.R., AHMADIAN M.R., NEURATH M.F. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J. Clin. Invest., 2003 April, 111(8): 1133-45.
51. ELLIOTT M.J., MAINI R.N., FELDMANN M., LONG-FOX A., CHARLES P., KATSIKIS P., BRENNAN P.M., WALKER J., BIJL H., GHRAYEB J. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum., 1993 December, 36 (12) : 1681-90.
52. MORELAND L.W., BAUMGARTNER S.W., SCHIFF M.H., TINDALL E.A., FLEISCHMANN R.M., WEAVER A.L., ETTLINGER R.E., COHEN S., KOOPMAN W.J., MOHLER K., WIDMER M.B., BLOSCH C.M. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med., 1997 July 17, 337 (3) : 141-7.
53. VAN DEN BRANDE J.M., BRAAT H., VAN DEN BRINK G.R., VERSTEEG H.H., BAUER C.A., HOEDEMAEKER I., VAN M.C., HOMMES D.W., PEPPELENBOSCH M.P., VAN DEVENTER S.J. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology, 2003 June, 124 (7) : 1774-85.
54. TEN HOVE T., VAN MONTFRANS C., PEPPELENBOSCH M.P., VAN DEVENTER S.J. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut, 2002 February, 50 (2) : 206-11.
55. ATREYA R., MUDTER J., FINOTTO S., MULLBERG J., JOSTOCK T., WIRTZ S., SCHUTZ M., BARTSCH B., HOLTMANN M., BECKER C., STRAND D., CZAJA J., SCHLAAK J.F., LEHR HA., AUTSCHBACH F., SCHURMANN G., NISHIMOTO N., YOSHIZAKI K., ITO H., KISHIMOTO T., GALLE P.R., ROSE-JOHN S., NEURATH M.F. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation : evidence in crohn disease and experimental colitis in vivo. Nat. Med., 2000 May, 6 (5) : 583-8.
56. ITO H., HIROTANI T., YAMAMOTO M., OGAWA H., KISHIMOTO T. Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn's disease. J. Gastroenterol., 2002 November, 37 Suppl 14 : 56-61.
57. MUDTER J., WIRTZ S., GALLE P.R., NEURATH M.F. A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells : insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology, 2002, 70 (3) : 170-6.
58. FUSS I.J., MARTH T., NEURATH M.F., PEARLSTEIN G.R., JAIN A., STROBER W. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology, 1999 November, 117 (5) : 1078-88.
59. FICHTNER-FEIGL S., FUSS I.J., PREISS J.C., STROBER W., KITANI A. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J. Clin. Invest., 2005 November, 115 (11): 3057-71.
60. XU X.M., YU J.P., HE X.F., LI J.H., YU L.L., YU H.G. Effects of garlicin on apoptosis in rat model of colitis. World J. Gastroenterol., 2005 August 7. 11 (29) : 4579-82.
61. MARTIN A.R., VILLEGAS I., LA CASA C., DE LA LASTRA C.A. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonie inflammation in rats. Biochem. Pharmacol., 2004 April 1, 67 (7) : 1399-410.
62. OHMAN L., WILLEN R., HULTGREN O.H., HULTGREN H.E. Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice. Clin. Exp. Immunol., 2005 July, 141 (1) : 37-46.